Breakthroughs in Chronic Lymphocytic Leukemia from ASH 2011

Dr. Steven Rosen, Director of the Lurie Cancer Center in Chicago, shares his perspective on the latest news from the American Society of Hematology's 2011 annual meeting, focused around major advances in Chronic Lymphocytic Leukemia (CLL). A new, non-chemotherapy approach may provide a better tolerated approach to treating the disease, especially for older patients and those with genetic variations that do not respond to the current standard of care.